Definium Therapeutics, Inc. · Brief

Next report

2 days

Nov 5 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±12.8%implied · report alone

28.3036.64

straddle ±15.2%

spot 32.47exp Nov 20ATM strike 32ATM straddle 5.80IV 102%

Nov 2 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

—≥ implied

May 8 '25—▼−1.97%—

Jul 31 '25—▼−7.15%—

Q3 FY25—▲+3.72%—

Nov 6 '25—▲+3.17%—

Jan 12 '26—▲+0.29%—

Q1 FY26±12.9%▲+0.93%×0.07

May 7 '26±9.7%▼−4.96%×0.51

Q2 FY26±20.9%0.00%×0.00

quarterimplied−25%0+25%realized×

Q2 FY26±20.9%0.00%×0.00

May '26±9.7%▼−4.96%×0.51

Q1 FY26±12.9%▲+0.93%×0.07

Jan '26—▲+0.29%—

Nov '25—▲+3.17%—

Q3 FY25—▲+3.72%—

2 older reports

Jul '25—▼−7.15%—

May '25—▼−1.97%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

364managers reporting a position in institutional filings across the latest reporting date13F · Jun 30 '26

1 of 21largest reporting managers who reduced their stake in the latest quarter13F · Jun 30 '26

Bear1

39managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

DFTX report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 22impliedImplied move: ±11.6% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.